The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant and neoadjuvant evaluation of a structural variant-based MRD assay in early breast cancer: A real-world cohort.
 
Jason Carey
Employment - GRAIL; SAGA Diagnostics
Stock and Other Ownership Interests - GRAIL; SAGA Diagnostics
Travel, Accommodations, Expenses - GRAIL; SAGA Diagnostics
 
Jennifer Yen
Employment - Exai Bio; SAGA Diagnostics
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health - cfDNA analyses; Guardant Health - cfDNA analyses
Travel, Accommodations, Expenses - Exai Bio; SAGA Diagnostics; SAGA Diagnostics; SAGA Diagnostics
 
Daniel Sumarriva
Employment - SAGA Diagnostics
Stock and Other Ownership Interests - SAGA Diagnostics
Travel, Accommodations, Expenses - SAGA Diagnostics
 
Taryn Cranford
Employment - SAGA Diagnostics
Stock and Other Ownership Interests - SAGA Diagnostics
Travel, Accommodations, Expenses - SAGA Diagnostics
 
Karen Howarth
Employment - NeoGenomics Laboratories; SAGA Diagnostics
Stock and Other Ownership Interests - NeoGenomics Laboratories; SAGA Diagnostics
 
Wassim McHayleh
Stock and Other Ownership Interests - Relay Therapeutics
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Lilly; Natera; Stemline Therapeutics
Speakers' Bureau - Agendia; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Merck; Natera; Pfizer; Stemline Therapeutics